SavedAdd your journal

Journals / Endokrinolojide Diyalog Dergisi / 2013 / Cilt: 10 - Sayı: 1

Diabetes and melatonin pankreatik vazoaktif intestinal peptid üreten tümör (VIPoma): vaka sunumu ve literatür derlemesi

Pancreatic vasoactive intestinal peptide producing tumour (VIPoma): a case report and literature review

Huai Heng LOH
Florence TAN
Pages
32–37
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prompt recognition and early diagnosis are crucial to allow early intervention and improve outcome for thisraredisease

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vasoactive Intestinal Peptide-producing tumour (VIPoma) is rare.
📊
Key Findings & Data:We report a case of VIPoma presenting with severe Vernor-Morrison syndrome requiring intensive care and a review of recent English literature from year 2000 till 2010 for this rare disease.
💡
Conclusion & Impact:Prompt recognition and early diagnosis are crucial to allow early intervention and improve outcome for thisraredisease
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Vasoactive Intestinal Peptide-producing tumour (VIPoma) is rare. It typically causes the Vernor-Morrison syndrome characterized by watery diarrhoea, hypokalemia and achlorydria/acidosis. We report a case of VIPoma presenting with severe Vernor-Morrison syndrome requiring intensive care and a review of recent English literature from year 2000 till 2010 for this rare disease. Prompt recognition and early diagnosis are crucial to allow early intervention and improve outcome for thisraredisease

Özet

Pankreatik vazoaktif intestinal peptid üreten tümör (VIPoma) nadiren görülmektedir. Genellikle Vernor- Morrison sendromuna yol açmaktadır ve bu sendrom sulu dışkılama, hipokalemi ve aklorhidri/asidoz ile karakterizedir. Burada kendini ciddi Vernor-Morrison sendromu ile ortaya koyan VIPoma vakasından ve 2000-2010 yılları arasındaki İngiliz literatürünün derleme sonuçlarından bahsedilmektedir. Erken tanı bu nadir görülen hastalığın tedavisinde ve sağkalımında önemlidir.

🔖

Cite This Article

LOH, H. H., TAN, F. (2022). Diabetes and melatonin pankreatik vazoaktif intestinal peptid üreten tümör (VIPoma): vaka sunumu ve literatür derlemesi. Endokrinolojide Diyalog Dergisi, Cilt: 10 - Sayı: 1, 32–37. https://ajindex.com/articles/500707

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. 1 Friesen SR. Update on the diagnosis and treatment of rare neuroendocrine tumors. Surg Clin North Am 1987
  2. 2 Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958
  3. 374–80. 3 Soga J, Yakuwa Y. Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998
  4. 389–400. 4 Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ. Pancreatic VIPomas: Subject review and one institutional experience. J Gastrointest Surg 2008
  5. 5 Smith SL, Branton SA, Avino AJ, et al. Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery 1998
  6. 6 Nikou GC, Toubanakis C, Niklolaou P, et al. VIPomas: An up- date in diagnosis and management in a series of 11 patients. Hepatogastroenterology 2005
  7. 7 Peng SY, Li JT, Liu YB, et al. Diagnosis and treatment of VIPoma in China (case report and 31 cases review): Diagnosis and Treatment of VIPoma. Pancreas 2004
  8. 8 Longo C, Gulizia J, Larsen J. A case of vasoactive intestinal polypeptide-secreting tumor presenting without diarrhea in the setting of multiple endocrine neoplasia type I syndrome. Endocrinologist 2005
  9. 9 Bieligk SC, Jaffe BM. VIPOMA. In: Percopo V, Kaplan EL (Eds). GEP and Multiple Neuroendocrine Tumors. Piccin Nuova Libraria S.p.A, Italy, 1996: pp 357-369. 10 Bennett LAT, Johnson JM, Stephens DP, Saad AR, Kellogg Jr DL. Evidence for a role of Vasoactive Intestinal Peptide in active vasodilatation in the cutaneous vasculature in humans. J Physiol 2003
  10. 11 Remme CA, de Groot GH, Schrijver G. Diagnosis and treatment of VIPoma in a female patient. Eur J Gastroen Hepat 2006
  11. 12 Schoevaerdts D, Favet L, Zekry D, Sieber CC, Michel JP. VIPOMA: effective treatment with octrotide in the oldest old. J Am Geriatr Soc 2001
  12. 13 Pratz KW, Cynthia Ma, Aubry MC, Vrtiska TJ, Erlichman C. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome. Mayo Clin Proc 2005
  13. 14 Arnold R, Simon B, Wied M. Treatment of neuroendocrine GEP tumours with Somatostatin analogues. Digestion 2000
  14. 62 suppl 1:84-91. 15 Wynick D, Anderson JV, Williams SJ, Bloom SR. Resistance of metastatic pancreatic endocrine tumours after long-term treatment with the somatostatin analogue octreotide. Clin Endocrinol 1989
  15. 16 Song SW, Rui Shi,